Clinical Trial Update: Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy [NA]

View source ↗

Summary

Clinical trial update reporting completion of a study evaluating autologous immune cell therapy in patients with primary hepatocellular carcinoma after surgical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Autologous Immune Cell Therapy

Snippet

Sponsor: Shanghai AbelZeta Ltd. | Conditions: Primary Hepatocellular Carcinoma | NA | Status: COMPLETED